You are here: Home :: Area NEM :: Medical science :: Human medicine

Dsir Collen, H. Roger Lijnen

Thrombolytic agents

Thrombolytic agents are plasminogen activators that convert the zymogen plasminogen to the active enzyme plasmin, which degrades fibrin. Elucidation of the molecular mechanism of physiological fibrinolysis opened up a new era of fibrin-specific thrombolysis. Fibrin-specific plasminogen activators, including tissue-type plasminogen activator (t-PA), single-chain urokinasetype plasminogen activator (scu-PA) and staphylokinase (Sak), preferentially activate fibrin-associated plasminogen. Generated plasmin remains associated with fibrin, where it is protected from rapid inhibition and can efficiently degrade fibrin, avoiding systemic activation of the fibrinolytic system. Following a decade of clinical investigation t-PA and variants thereof are routinely used for treatment of patients with thromboembolic disease.

Thrombosis and Haemostasis, Schattauer

Print ISSN: 0340-6245
Volume: 93, 04/2005
Pages: 627 - 630

Show full article (external site)

Show all available items of this journal

 

Area NEM